Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-study

NCT03911466 is registered in ClinicalTrials.gov with T. John Winhusen, PhD as lead sponsor.

NCT NCT03911466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-study
Lead sponsor
T. John Winhusen, PhD
Phase
Observational
Overall status
Completed
Start date
July 21, 2020
Completion date
November 6, 2024
Enrollment
97 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, drug abuse in pregnancy, drug addiction, neonatal abstinence syndrome, neonatal opioid withdrawal syndrome, opioid-related disorders, pregnancy related, substance abuse